Relay Therapeutics, Inc.
RLAY
$2.83
-$0.28-9.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.40% | 13.73% | 4.45% | -13.30% | 2.52% |
| Total Depreciation and Amortization | -9.45% | -2.41% | -0.07% | -1.94% | 1.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.47% | -20.48% | 58.68% | -43.91% | 60.31% |
| Change in Net Operating Assets | -1,140.79% | 118.94% | -159.57% | 60.99% | 138.73% |
| Cash from Operations | -26.51% | 22.93% | -14.05% | -30.82% | 43.58% |
| Capital Expenditure | -- | 100.00% | -1,963.64% | 99.38% | -1,408.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.77% | 123.03% | -376.41% | 270.08% | -79.41% |
| Cash from Investing | 46.44% | 122.98% | -376.97% | 332.53% | -82.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.63% | 14,095.14% | -96.85% | 123.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -99.63% | 14,095.14% | -96.85% | 123.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.53% | -259.09% | 194.15% | -305.27% | 220.26% |